| 发明名称 |
4-Amino-5-Fluoro-3-[6-(4-Methylpiperazin-1-YL)-1H-Benzimidazol-2-YL]-1H-Quinolin-2-one for use in the Treatment of Adenoid Cystic Carcinoma |
| 摘要 |
The present invention describes a method of reducing solid tumors in a subject having an adenoid cystic carcinoma comprising administering a therapeutically effective amount of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-yl]-1H-quinolin-2-one or a pharmaceutically acceptable salt thereof. |
| 申请公布号 |
US2015182525(A1) |
申请公布日期 |
2015.07.02 |
| 申请号 |
US201214117057 |
申请日期 |
2012.05.18 |
| 申请人 |
Shi Michael;Wick Michael |
发明人 |
Shi Michael;Wick Michael |
| 分类号 |
A61K31/496;A61K31/337 |
主分类号 |
A61K31/496 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one or a tautomer or a pharmaceutically acceptable salt therof for use in the treatment of adenoid cystic carcinoma. |
| 地址 |
Chalfont PA US |
